Healthcare

Encouraging policy action to address the psoriasis challenge

April 03, 2017

Global

April 03, 2017

Global
Edel McCormack

Deputy editor, EMEA

Edel is a deputy editor for The Economist Intelligence Unit's Thought Leadership division in EMEA. She works on bespoke research and thought leadership programmes in the areas of finance, healthcare and sustainability. From 2013 to October 2015 she worked as editorial coordinator supporting the EIU's Country Analysis, Custom Research and Global Forecasting teams. Additionally, she works as a freelance political and economics contributor covering politics, economics and industry trends in Africa. She holds an International BA in English and French, and Masters in Media and International Conflict.  

Contact

Psoriasis is an autoimmune skin disease which affects 1.5-5% of the population of most developed countries and an estimated 125m people worldwide.

This report examines how health systems in Europe and Canada are responding to the World Health Organisation’s support for worldwide action against psoriasis, an autoimmune disease. The findings of this report, commissioned by Eli Lilly and Company, are based on research by The Economist Intelligence Unit and include insights from leading psoriasis experts in academia and the medical profession as well as patients and patient association leaders.

Receive forward-looking perspectives from our editors - Subscribe now for our Weekly Digest